Gambogic amide
Product Specifications
CAS Number
286935-60-2
Target
Akt, ERK, Trk receptor
Related Pathways
PI3K/Akt/mTOR signaling, Cytoskeletal Signaling, MAPK, Tyrosine Kinase/Adaptors
Bioactivity
Gambogic amide acts as a potent and selective agonist for TrkA, promoting tyrosine phosphorylation and activating downstream signaling pathways such as Akt and MAPK. It specifically binds to the cytoplasmic juxtamembrane domain of the TrkA receptor, stimulating dimerization and activation. The compound demonstrates neuroprotective properties by preventing neuronal cell death caused by glutamate. Additionally, gambogic amide shows enhanced efficacy in a transient middle cerebral artery occlusion model of stroke and may be useful for investigating neurodegenerative diseases and stroke [1].
Smiles
C(/C=C(\C(N)=O)/C)[C@@]12[C@]34C(C(=O)C=5C(O3)=C(CC=C(C)C)C6=C(C5O)C=C[C@](CCC=C(C)C)(C)O6)=CC(C1=O)(C[C@]4(C(C)(C)O2)[H])[H]
Molecular Formula
C38H45NO7
Molecular Weight
627.77
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
C13309 100 µL
PRKD1/2/3 (phospho-Ser738/Ser742) Conjugated Antibody
Sign In for Pricing
View Details NBP3-08671JF646 100 µL
Mouse Monoclonal BarX1 Antibody (BARX1/2760) [Janelia Fluor 646]
Sign In for Pricing
View Details 